In addition, the Vitamin E derivative δ-tocotrienol was shown to exert a specific anti-tumor activity against melanoma CSCs [70] and as such could be tested in combination treatment with TGFβ to target specifically melanoma stem cells. This evidence concerns the gene TGFB1 and neoplasm.